Two Case Reports of Zolpidem Abuse and a Contemporary Review

两例唑吡坦滥用病例报告及当代综述

阅读:1

Abstract

Zolpidem is a short-acting nonbenzodiazepine hypnotic agent. It was commonly considered a preferable treatment for insomnia because it was associated with low risks of abuse and dependency. However, those risks were underestimated, and the withdrawal symptoms associated with zolpidem can be life-threatening. Moreover, besides the gradual discontinuation of the long-term (≥4 wk) prescription of zolpidem, other effective strategies for zolpidem detoxification are being explored. We report 2 cases of zolpidem abuse with daily doses of 800 and 240 mg, respectively. The patients were successfully detoxified with clonazepam, trazodone, quetiapine, and simplified cognitive behavioral therapy for insomnia (CBT-I) without experiencing any significant withdrawal symptoms. Shifting from zolpidem to benzodiazepines with longer half-lives and gradual dose tapering may be useful in patients with zolpidem abuse. In addition to pharmacotherapy, simplified CBT-I can be helpful.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。